Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
Top Cited Papers
- 1 February 2017
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (2) , 249-255
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug TargetsCold Spring Harbor Perspectives in Medicine, 2015
- Reporting genomic secondary findings: ACMG members weigh inGenetics in Medicine, 2015
- ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencingGenetics in Medicine, 2015
- Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts (December 2013 Report of the Presidential Commission for the Study of Bioethical Issues)American Journal of Epidemiology, 2014
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Mutations in Myosin Light Chain Kinase Cause Familial Aortic DissectionsThe American Journal of Human Genetics, 2010
- Diagnosis and treatment of Wilson disease: An updateHepatology, 2008
- Wilson's diseaseThe Lancet, 2007
- Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiencyAnnals of Neurology, 2003
- Risk of serious illness in heterozygotes for ornithine transcarbamylase deficencyThe Journal of Pediatrics, 1986